LMCG Investments’s Quest Diagnostics DGX Stock Holding History

LMCG Investments’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$8M	Buy	130,196 +5,282	+4%	+$369K	0.17%	234
2015 Q2	$9.06M	Sell	124,914 -38,639	-24%	-$2.85M	0.2%	207
2015 Q1	$12.6M	Sell	163,553 -45,328	-22%	-$3.25M	0.26%	155
2014 Q4	$14M	Sell	208,881 -11,833	-5%	-$747K	0.31%	124
2014 Q3	$13.4M	Buy	220,714 +22,453	+11%	+$1.38M	0.3%	136
2014 Q2	$11.6M	Buy	198,261 +1,809	+0.9%	+$106K	0.25%	162
2014 Q1	$11.4M	Buy	196,452 +11,695	+6%	+$627K	0.25%	165
2013 Q4	$9.89M	Buy	184,757 +31,554	+21%	+$1.87M	0.21%	191
2013 Q3	$9.47M	Buy	153,203 +39,505	+35%	+$2.36M	0.23%	164
2013 Q2	$6.89M	Buy	+113,698	New	+$6.77M	0.18%	193

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

LMCG Investments's DGX Position: Q3 2015 in Review

LMCG Investments increased its Quest Diagnostics (DGX) stake by 4.2% in Q3 2015, buying an estimated $369K and bringing the position to 130,196 shares worth $8M. The position accounts for 0.17% of the portfolio, ranked #234.

LMCG Investments first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $14M in Q4 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

LMCG Investments held 130,196 shares of Quest Diagnostics worth $8M as of Q3 2015.
LMCG Investments bought 5,282 Quest Diagnostics shares in Q3 2015, an estimated $369K.
Quest Diagnostics made up 0.17% of LMCG Investments's portfolio in Q3 2015, its #234 holding.
LMCG Investments first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
LMCG Investments's Quest Diagnostics position peaked at $14M in Q4 2014.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.